Pediatric Preparedness of the Emergency Departments

Peck Har Ang1, Shu-Ling Chong2, Yong-Kwang Gene Ong2

  • 1From the Accident and Emergency Department, Changi General Hospital, SingHealth.

Pediatric Emergency Care
|October 21, 2020
PubMed

Insights

Preparedness for pediatric emergency care varied across emergency departments (EDs). General EDs showed lower adherence to Royal College of Pediatrics and Child Health (RCPCH) and International Federation for Emergency Medicine (IFEM) standards compared to pediatric EDs.

Area of Science:

  • Emergency Medicine
  • Pediatric Care
  • Healthcare Quality Improvement

Background:

  • Emergency departments (EDs) exhibit variability in their readiness for pediatric emergency care.
  • Higher mortality rates are associated with unprepared EDs.
  • Established guidelines exist to enhance ED preparedness for pediatric emergencies.

Purpose of the Study:

  • To assess the preparedness of EDs within a specific healthcare cluster for pediatric emergency care.
  • To utilize guidelines from the Royal College of Pediatrics and Child Health (RCPCH) and the International Federation for Emergency Medicine (IFEM) as audit references.

Main Methods:

  • A cross-sectional study was conducted across one pediatric ED and three general EDs.
  • A survey was administered to pediatric representatives in each ED to evaluate adherence to standards in 2018.
  • Availability of pediatric equipment, supplies, and medications was verified against IFEM recommendations.

Main Results:

  • General EDs demonstrated lower agreement with RCPCH (11.4%-70.0%) and IFEM (39.6%-84.0%) standards compared to the pediatric ED (RCPCH: 85.7%, IFEM: 91.7%).
  • Commonly unmet standards included complex pediatric cases, pediatric death management, adolescent care, mental health, safeguarding, and advanced training.
  • General EDs had lower availability of essential pediatric equipment, supplies, and medications (77.2%-82.0%) than the pediatric ED (89.4%).

Conclusions:

  • Pediatric emergency care standards are inconsistently met across the healthcare cluster.
  • EDs must identify and address specific deficiencies using available guidelines to improve pediatric emergency care delivery.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
126
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
133
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
130
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
155
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
328
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
105